Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Interest & Investment Income for 5 consecutive years, with $58000.0 as the latest value for Q1 2020.

  • Quarterly Interest & Investment Income fell 89.28% to $58000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2020, down 38.58% year-over-year, with the annual reading at $1.6 million for FY2019, 1.96% up from the prior year.
  • Interest & Investment Income for Q1 2020 was $58000.0 at Forte Biosciences, down from $197000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $541000.0 in Q1 2019, with the low at $37000.0 in Q1 2017.
  • Average Interest & Investment Income over 5 years is $233294.1, with a median of $214000.0 recorded in 2017.
  • The sharpest move saw Interest & Investment Income soared 751.35% in 2018, then plummeted 89.28% in 2020.
  • Over 5 years, Interest & Investment Income stood at $45000.0 in 2016, then surged by 435.56% to $241000.0 in 2017, then surged by 85.48% to $447000.0 in 2018, then crashed by 55.93% to $197000.0 in 2019, then crashed by 70.56% to $58000.0 in 2020.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $58000.0, $197000.0, and $361000.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.